Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer

Clinical trial NCT06336902 · RECRUITING

Trial details

NCT number: NCT06336902
Sponsor: University of Southern California
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Colorectal Adenocarcinoma Stage IV Colorectal Cancer AJCC v8

Start date: 2025-01-15
Primary completion: 2027-01-15
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.